WPRIM Management System> DCMS> Blood Research> 2021> 56> S1

Volume: 56 Issue: S1

1. Genomics of diffuse large B cell lymphoma Page:S75—S79
2. Immuno-oncology for B-cell lymphomas Page:S70—S74
3. Myelodysplastic syndromes and overlap syndromes Page:S51—S64
4. The clinical role of interferon alpha in Philadelphia-negative myeloproliferative neoplasms Page:S44—S50
5. Molecular basis and diagnosis of thalassemia Page:S39—S43
6. Myelodysplastic syndrome with genetic predisposition Page:S34—S38
7. Disease modifying agents of myeloproliferative neoplasms: a review Page:S26—S33
8. Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults Page:S17—S25
9. Diagnosis and treatment of chronic myelomonocytic leukemia Page:S5—S16
10. Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas Page:S1—S4
11. Genomics of diffuse large B cell lymphoma Page:S75—S79
12. Immuno-oncology for B-cell lymphomas Page:S70—S74
13. Myelodysplastic syndromes and overlap syndromes Page:S51—S64
14. The clinical role of interferon alpha in Philadelphia-negative myeloproliferative neoplasms Page:S44—S50
15. Molecular basis and diagnosis of thalassemia Page:S39—S43
16. Myelodysplastic syndrome with genetic predisposition Page:S34—S38
17. Disease modifying agents of myeloproliferative neoplasms: a review Page:S26—S33
18. Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults Page:S17—S25
19. Diagnosis and treatment of chronic myelomonocytic leukemia Page:S5—S16
20. Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas Page:S1—S4

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.